Helsinki University Central Hospital
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Private
- Established
- 1958-03-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.hus.fi
Clinical Trials
344
Active:67
Completed:164
Trial Phases
5 Phases
Phase 1:19
Phase 2:15
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (237 trials with phase data)• Click on a phase to view related trials
Not Applicable
159 (67.1%)Phase 4
40 (16.9%)Phase 1
19 (8.0%)Phase 2
15 (6.3%)Phase 3
4 (1.7%)Methacholine Challenge Test in School Children With/Without Asthma RISKA
Recruiting
- Conditions
- Asthma BronchialeLung Function TestsBronchial Hyperresponsiveness
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 260
- Registration Number
- NCT07031102
- Locations
- 🇫🇮
HUS Skin and Allergy Hospital, Helsinki, Finland
ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
Not Applicable
Not yet recruiting
- Conditions
- Cholecystectomy, LaparoscopicCholedocholithiasisCholelithiasis
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT07001423
- Locations
- 🇫🇮
Helsinki University Hospital, Jorvi, Espoo, Finland
🇫🇮Helsinki University Hospital, Meilahti, Helsinki, Finland
🇫🇮Kanta-Häme Central Hospital, Hämeenlinna, Finland
A Trial in Mini-invasive Pilonidal Sinus Disease Surgery
Not Applicable
- Conditions
- Pilonidal Disease
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 188
- Registration Number
- NCT06964763
- Locations
- 🇫🇮
HUS Vatsakeskus Abdominal Center of Helsinki University Hospital, Helsinki, Finland
Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
- Conditions
- Non-alcoholic Fatty Liver Disease (NAFLD)
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06942312
- Locations
- 🇫🇮
Helsinki Central University Hospital, Helsinki, Uusimaa, Finland
The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
Phase 2
Recruiting
- Conditions
- Kidney FailureParaproteinemiasGlomerulonephritis
- Interventions
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06889948
- Locations
- 🇫🇮
Helsinki University Hospital, Helsinki, Finland
- Prev
- 1
- 2
- 3
- 4
- 5
- 60
- Next
News
No news found